1-197040740-GAAC-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_001994.3(F13B):​c.1739-8_1739-6delGTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00186 in 1,593,662 control chromosomes in the GnomAD database, including 5 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 5 hom. )

Consequence

F13B
NM_001994.3 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.946

Publications

0 publications found
Variant links:
Genes affected
F13B (HGNC:3534): (coagulation factor XIII B chain) This gene encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13B Gene-Disease associations (from GenCC):
  • factor XIII, b subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 1-197040740-GAAC-G is Benign according to our data. Variant chr1-197040740-GAAC-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 294571.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2}.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00184 (280/151848) while in subpopulation AMR AF = 0.00664 (101/15222). AF 95% confidence interval is 0.00559. There are 0 homozygotes in GnomAd4. There are 154 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F13BNM_001994.3 linkc.1739-8_1739-6delGTT splice_region_variant, intron_variant Intron 10 of 11 ENST00000367412.2 NP_001985.2 P05160

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F13BENST00000367412.2 linkc.1739-8_1739-6delGTT splice_region_variant, intron_variant Intron 10 of 11 1 NM_001994.3 ENSP00000356382.2 P05160
F13BENST00000649282.1 linkc.494-8_494-6delGTT splice_region_variant, intron_variant Intron 3 of 4 ENSP00000497116.1 A0A3B3IS66
F13BENST00000490002.1 linkn.150-8_150-6delGTT splice_region_variant, intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.00185
AC:
280
AN:
151730
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000630
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00664
Gnomad ASJ
AF:
0.000289
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00208
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00163
AC:
385
AN:
236506
AF XY:
0.00155
show subpopulations
Gnomad AFR exome
AF:
0.000522
Gnomad AMR exome
AF:
0.00470
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000471
Gnomad NFE exome
AF:
0.00196
Gnomad OTH exome
AF:
0.00241
GnomAD4 exome
AF:
0.00187
AC:
2692
AN:
1441814
Hom.:
5
AF XY:
0.00181
AC XY:
1296
AN XY:
717694
show subpopulations
African (AFR)
AF:
0.000396
AC:
13
AN:
32812
American (AMR)
AF:
0.00434
AC:
189
AN:
43510
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25874
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39372
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84164
European-Finnish (FIN)
AF:
0.0000942
AC:
5
AN:
53096
Middle Eastern (MID)
AF:
0.000177
AC:
1
AN:
5634
European-Non Finnish (NFE)
AF:
0.00219
AC:
2404
AN:
1097784
Other (OTH)
AF:
0.00134
AC:
80
AN:
59568
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
124
248
372
496
620
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00184
AC:
280
AN:
151848
Hom.:
0
Cov.:
32
AF XY:
0.00207
AC XY:
154
AN XY:
74220
show subpopulations
African (AFR)
AF:
0.000628
AC:
26
AN:
41416
American (AMR)
AF:
0.00664
AC:
101
AN:
15222
Ashkenazi Jewish (ASJ)
AF:
0.000289
AC:
1
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10536
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00208
AC:
141
AN:
67916
Other (OTH)
AF:
0.00521
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00142
Hom.:
0
Bravo
AF:
0.00219
Asia WGS
AF:
0.000289
AC:
1
AN:
3474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

F13B: BP4 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Factor XIII, b subunit, deficiency of Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.95
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs556380704; hg19: chr1-197009870; API